All stock lists
EPAM Systems, Inc. (New York Stock Exchange:EPAM)
US · Delayed Price · Currency is USD
Technology · Information Technology Services
138.17-5.63 (-3.92%)
Market cap
$7.13B
Insider Score
Health Score
Analyst consensus
Listed since
Feb 8, 2012
Website
Insider Score
––Not scored
EPAM Insider Score
Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
EPAM analyst forecast
EPAM analyst consensus
Moderate Buy9 ratings
Buy 5 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
EPAM 12-month price target
$160.00+15.8% upsideaverage of 1 firm
$160.00High
$160.00Low
EPAM ratings mix, last 12 months
Buy Hold Sell
Best analysts covering EPAM
- Needham7%success rate · -17.0% avg return · 14 calls
- Susquehanna0%success rate · -22.9% avg return · 9 calls
- JP Morgan0%success rate · -22.3% avg return · 6 calls
- Mizuho0%success rate · -14.5% avg return · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
EPAM analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Guggenheim | Buy | $160.00 | +13.9% | Reiterated | 2026-11-02 | |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-10-26 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-10-26 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2026-08-26 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-08-10 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-08-07 |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-08-07 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-08-07 |
| — | Susquehanna | Positive | — | — | Reiterated | 2026-08-07 |
| — | Needham | Buy | — | — | Reiterated | 2026-08-06 |
| — | William Blair | Market Perform | — | — | Downgraded | 2026-08-06 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-08-04 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-07-27 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-07-10 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-07-09 |
| — | Jefferies | Hold | — | — | Downgraded | 2026-05-29 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-05-08 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-05-08 |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-05-08 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-05-08 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2026-05-08 |
| — | Needham | Buy | — | — | Reiterated | 2026-05-07 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-05-05 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-05-04 |
| — | Susquehanna | Positive | — | — | Reiterated | 2026-05-04 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-04-09 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-04-06 |
| — | Needham | Buy | — | — | Reiterated | 2026-03-16 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-03-16 |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-02-20 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-02-20 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-02-20 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-20 |
| — | Needham | Buy | — | — | Reiterated | 2026-02-20 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-02-20 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-01-29 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-01-14 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-01-09 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-11-11 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-11-07 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-09-09 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-08-20 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-05-12 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2025-05-09 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-05-09 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-05-09 |
| — | Needham | Buy | — | — | Reiterated | 2025-05-09 |
| — | Stifel | Buy | — | — | Reiterated | 2025-05-02 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-04-29 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-04-25 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-04-25 |
| — | Susquehanna | Positive | — | — | Reiterated | 2025-04-23 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2025-04-16 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-03-10 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-02-24 |
| — | Needham | Buy | — | — | Reiterated | 2025-02-20 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-01-31 |
| — | Jefferies | Buy | — | — | Reiterated | 2025-01-21 |
| — | Barclays | Overweight | — | — | Upgraded | 2024-12-17 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2024-12-06 |
EPAM earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-06 | 3.03 | 3.08 | $1.38B | $1.39B |
| 2026-02-19 | 3.16 | 3.26 | $1.39B | $1.41B |
| 2026-05-07 | 2.75 | 2.86 | $1.39B | $1.40B |
| 2026-08-06 | 3.16 | 3.38 | $1.41B | $1.41B |
| 2026-11-05Upcoming | 3.41 | — | $1.42B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.